论文部分内容阅读
目的:探讨妊娠合并子宫肌瘤红色变性采用小剂量肝素治疗的临床疗效。方法:选取我院自2012年1月至2013年1月收治的80例妊娠合并子宫肌瘤红色变性患者,随机将其分为观察组和对照组,各40例,对照组患者行硫酸镁联合葡萄糖注射液治疗,观察组则在对照组治疗的基础上加行小剂量肝素治疗,对两组患者的治疗总有效率进行对比。结果:观察组患者的治疗总有效率为95.0%,对照组患者的治疗总有效率为50.0%,观察组明显高于对照组(P<0.05),结论:在常规治疗的基础上给予妊娠合并子宫肌瘤红色变性患者小剂量肝素治疗可有效的提高治疗效果,值得临床推广和应用。
Objective: To investigate the clinical efficacy of low-dose heparin treatment for pregnancy with uterine fibroids red degeneration. Methods: 80 patients with red degeneration of uterine fibroids in our hospital from January 2012 to January 2013 were randomly divided into observation group and control group, 40 cases in each group. Patients in the control group were treated with magnesium sulfate Glucose injection, the observation group was treated with low-dose heparin on the basis of the control group, the total effective rate was compared between the two groups of patients. Results: The total effective rate was 95.0% in the observation group and 50.0% in the control group. The observation group was significantly higher than the control group (P <0.05). Conclusion: On the basis of routine treatment, Uterine fibroids red degeneration patients with low-dose heparin therapy can effectively improve the treatment effect, it is worth clinical promotion and application.